UNSPSC 51203402: Cladribine

This classification denotes a radiosensitizing agent and purine antagonist with the molecular formula C10H12ClN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 47M74X9YT5, chemically known as adenosine, 2-chloro-2-deoxy- but more generally known as cladribine, which bears US NIH Compound Identifier 1546. European Medicines Agency schedules Cladribine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06635MIG.

UNSPSC 51203402 Cladribine is a Commodity code for a specific pharmaceutical active pharmaceutical ingredient, but state and local solicitation activity under this code shows minimal direct relevance to cladribine procurement. The recent opportunities recorded under this code reflect broader pharmaceutical and health-supply acquisitions by state and local health agencies, including antibiotic tablets, naloxone, and drug deactivation systems — categories that diverge substantially from the nominal cladribine classification. State and local health departments and county public health systems are the primary issuing bodies engaging in pharmaceutical procurement through cooperative purchasing vehicles such as MMCAP Infuse, which provides piggyback contracting authority to accelerate acquisition of commonly needed health commodities.

Activity under the code is geographically dispersed across at least Florida and Illinois, with recent opportunities reflecting episodic rather than sustained procurement volume. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, totaling $2,999,999.11 over three years; this was a completed Invitation for Bid award, not an open solicitation. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023 — a dates inconsistency in the source) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The code shows no open solicitations currently active for cladribine itself, and the mismatch between the code's nominal scope and the actual work being procured suggests this code may be applied inconsistently or that cladribine procurement through state and local channels occurs infrequently enough that it does not generate visible recent opportunity records.